Neurodegenerative Disease Research

About Seer Inc

Seer is a commercial-stage proteomics company focused on making the proteome—the entire set of proteins in a biological system—broadly accessible to researchers and clinicians. Its core technology, the Proteograph Product Suite, utilizes engineered nanoparticles and liquid chromatography-mass spectrometry (LC-MS) to perform deep, unbiased, and rapid proteomic analysis from minimal sample volumes. The company aims to transform the understanding of biology and disease by providing scalable tools that overcome the historical limitations of proteomics, positioning itself at the forefront of the next generation of life science research and diagnostics.

Therapeutic Areas